Development of immunotherapy in China

Collaborative care, cost and communication in oncology

Combining radiotherapy with immunotherapy

Biomarker driven clinical trials

A phase III study of buparlisib and fulvestrant in HR positive advanced breast cancer

Five years of letrozole does not improve disease free survival for pretreated HR positive breast cancer

Reducing chemo-associated hair loss with scalp cooling cap

Decoding breast cancer predisposition genes

Macrophage iron recycling in triple negative breast cancer

Results of the BELLE-3 study of buparlisib for advanced breast cancer

Epirubicin and cyclophosphamide before docetaxel in early breast cancer

Matched mutations and long term letrozole for breast cancer